Article
N-Terminal Pro-B-Type Natriuretic Peptide Testing Improves the Management of Patients With Suspected Acute Heart Failure. Primary Results of the Canadian Prospective Randomized Multicenter IMPROVE-CHF Study
Gordon W. Moe, Jonathan Howlett, James L. Januzzi, Hanna Zowall
and for the Canadian Multicenter Improved Management of Patients With Congestive Heart Failure (IMPROVE-CHF) Study Investigators
https://doi.org/10.1161/CIRCULATIONAHA.106.666255
Circulation. 2007;
Originally published June 4, 2007Gordon W. Moe
Jonathan Howlett
James L. Januzzi

This is a PDF-only article. The first page of the PDF of this article appears below.

Current Issue
Article Tools
- N-Terminal Pro-B-Type Natriuretic Peptide Testing Improves the Management of Patients With Suspected Acute Heart Failure. Primary Results of the Canadian Prospective Randomized Multicenter IMPROVE-CHF StudyGordon W. Moe, Jonathan Howlett, James L. Januzzi and Hanna Zowall for the Canadian Multicenter Improved Management of Patients With Congestive Heart Failure (IMPROVE-CHF) Study InvestigatorsCirculation. 2007;, originally published June 4, 2007https://doi.org/10.1161/CIRCULATIONAHA.106.666255
Citation Manager Formats
Share this Article
- N-Terminal Pro-B-Type Natriuretic Peptide Testing Improves the Management of Patients With Suspected Acute Heart Failure. Primary Results of the Canadian Prospective Randomized Multicenter IMPROVE-CHF StudyGordon W. Moe, Jonathan Howlett, James L. Januzzi and Hanna Zowall for the Canadian Multicenter Improved Management of Patients With Congestive Heart Failure (IMPROVE-CHF) Study InvestigatorsCirculation. 2007;, originally published June 4, 2007https://doi.org/10.1161/CIRCULATIONAHA.106.666255